$IZEA
IZEA Worldwide, Inc.

2021 Q3 Form 10-Q Financial Statement

#000149523121000130 Filed on August 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q3
Revenue $7.734M
YoY Change 83.82%
Cost Of Revenue $4.022M
YoY Change 129.75%
Gross Profit $3.712M
YoY Change 51.09%
Gross Profit Margin 47.99%
Selling, General & Admin $4.912M
YoY Change 52.05%
% of Gross Profit 132.32%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $220.5K
YoY Change -40.82%
% of Gross Profit 5.94%
Operating Expenses $4.912M
YoY Change 52.05%
Operating Profit -$1.420M
YoY Change 23.93%
Interest Expense $1.558K
YoY Change -90.53%
% of Operating Profit
Other Income/Expense, Net $19.40K
YoY Change 42.28%
Pretax Income -$1.481M
YoY Change 18.46%
Income Tax
% Of Pretax Income
Net Earnings -$1.401M
YoY Change 23.71%
Net Earnings / Revenue -18.11%
Basic Earnings Per Share
Diluted Earnings Per Share -$23.93K
COMMON SHARES
Basic Shares Outstanding 61.86M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $74.45M
YoY Change 143.15%
Cash & Equivalents $74.45M
Short-Term Investments
Other Short-Term Assets $40.85K
YoY Change -70.88%
Inventory
Prepaid Expenses $1.690M
Receivables $7.093M
Other Receivables $0.00
Total Short-Term Assets $83.28M
YoY Change 136.89%
LONG-TERM ASSETS
Property, Plant & Equipment $157.8K
YoY Change -39.55%
Goodwill $4.017M
YoY Change 0.0%
Intangibles $0.00
YoY Change -100.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $5.302M
YoY Change -18.77%
TOTAL ASSETS
Total Short-Term Assets $83.28M
Total Long-Term Assets $5.302M
Total Assets $88.58M
YoY Change 112.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.698M
YoY Change -2.6%
Accrued Expenses $2.420M
YoY Change 90.91%
Deferred Revenue $10.10M
YoY Change 56.36%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $31.31K
YoY Change -97.37%
Total Short-Term Liabilities $14.22M
YoY Change 33.79%
LONG-TERM LIABILITIES
Long-Term Debt $65.76K
YoY Change -92.17%
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $65.76K
YoY Change -92.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.22M
Total Long-Term Liabilities $65.76K
Total Liabilities $14.29M
YoY Change 24.52%
SHAREHOLDERS EQUITY
Retained Earnings -$73.95M
YoY Change 6.54%
Common Stock $6.190K
YoY Change 28.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $74.29M
YoY Change
Total Liabilities & Shareholders Equity $88.58M
YoY Change 112.51%

Cashflow Statement

Concept 2021 Q3
OPERATING ACTIVITIES
Net Income -$1.401M
YoY Change 23.71%
Depreciation, Depletion And Amortization $220.5K
YoY Change -40.82%
Cash From Operating Activities -$510.4K
YoY Change 629.11%
INVESTING ACTIVITIES
Capital Expenditures -$4.220K
YoY Change -97.66%
Acquisitions
YoY Change
Other Investing Activities $20.90K
YoY Change -119.0%
Cash From Investing Activities $16.68K
YoY Change -105.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -99.23K
YoY Change -100.98%
NET CHANGE
Cash From Operating Activities -510.4K
Cash From Investing Activities 16.68K
Cash From Financing Activities -99.23K
Net Change In Cash -592.9K
YoY Change -106.05%
FREE CASH FLOW
Cash From Operating Activities -$510.4K
Capital Expenditures -$4.220K
Free Cash Flow -$506.2K
YoY Change -560.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
dei Entity Central Index Key
EntityCentralIndexKey
0001495231
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
61864296 shares
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Address Address Line1
EntityAddressAddressLine1
1317 Edgewater Dr
dei Entity Address Address Line2
EntityAddressAddressLine2
#1880
dei Entity Address City Or Town
EntityAddressCityOrTown
Orlando
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61809573 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61809573 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50050167 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50050167 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61809573 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50050167 shares
izea Contractassetsandcontractliabilitieslengthofagreementwithcustomers
Contractassetsandcontractliabilitieslengthofagreementwithcustomers
P1Y
izea Lengthofcontractwithcustomers
Lengthofcontractwithcustomers
P1Y
izea Lengthofcontractwithcustomers
Lengthofcontractwithcustomers
P1Y
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37703
dei Entity Registrant Name
EntityRegistrantName
IZEA WORLDWIDE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-1530765
dei Entity Address Address Line1
EntityAddressAddressLine1
1317 Edgewater Dr
dei Entity Address Address Line2
EntityAddressAddressLine2
#1880
dei Entity Address City Or Town
EntityAddressCityOrTown
Orlando
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32789
dei City Area Code
CityAreaCode
407
dei Local Phone Number
LocalPhoneNumber
674-6911
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
IZEA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
61864296 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
74989876 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33045225 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6132949 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5207205 USD
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1006643 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
199294 USD
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
62694 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
74467 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
82192162 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
38526191 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
193786 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
230918 USD
CY2021Q2 us-gaap Goodwill
Goodwill
4016722 USD
CY2020Q4 us-gaap Goodwill
Goodwill
4016722 USD
CY2020Q4 us-gaap Goodwill
Goodwill
4016722 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
72222 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
505556 USD
CY2021Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1242252 USD
CY2020Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1472684 USD
CY2021Q2 us-gaap Assets
Assets
87717144 USD
CY2020Q4 us-gaap Assets
Assets
44752071 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1624725 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1880144 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2097474 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1924973 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8654765 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7180264 USD
CY2021Q2 us-gaap Notes Payable Current
NotesPayableCurrent
0 USD
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1477139 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
12376964 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12462520 USD
CY2021Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
34292 USD
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
43808 USD
CY2021Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
32255 USD
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
459383 USD
CY2021Q2 us-gaap Liabilities
Liabilities
12443511 USD
CY2020Q4 us-gaap Liabilities
Liabilities
12965711 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61809573 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61809573 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50050167 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50050167 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
6181 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
5005 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
148006352 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
102416131 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-72738900 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-70634776 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
75273633 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
31786360 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
87717144 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44752071 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6538739 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3135039 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11914371 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7898707 USD
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
3284259 USD
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
1414249 USD
us-gaap Cost Of Revenue
CostOfRevenue
5689011 USD
us-gaap Cost Of Revenue
CostOfRevenue
3554766 USD
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2302869 USD
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1228691 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4381192 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2751834 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2659578 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1920492 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5194725 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4338330 USD
CY2021Q2 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2020Q2 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
4300000 USD
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
363924 USD
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
377107 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
729453 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
878376 USD
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
8610630 USD
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
4940539 USD
us-gaap Costs And Expenses
CostsAndExpenses
15994381 USD
us-gaap Costs And Expenses
CostsAndExpenses
15823306 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2071891 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1805500 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4080010 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-7924599 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
8739 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
19476 USD
us-gaap Interest Expense
InterestExpense
22532 USD
us-gaap Interest Expense
InterestExpense
26094 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1968944 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
33834 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1998418 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3910 USD
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1960205 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
14358 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1975886 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30004 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-111686 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-1791142 USD
us-gaap Net Income Loss
NetIncomeLoss
-2104124 USD
us-gaap Net Income Loss
NetIncomeLoss
-7954603 USD
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
61386913 shares
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36108073 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
58874526 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35394639 shares
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
7713057 USD
CY2020Q2 izea Stock Issued During Period Value Sale Of Securities
StockIssuedDuringPeriodValueSaleOfSecurities
15361853 USD
CY2020Q2 izea Stock Issued During Period Value Employee Stock Purchase Plans And Stock Options Issued
StockIssuedDuringPeriodValueEmployeeStockPurchasePlansAndStockOptionsIssued
2313 USD
CY2020Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
31249 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
455706 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
118707 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-1791142 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
20980331 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
63298227 USD
CY2021Q2 izea Stock Issued During Period Value Sale Of Securities
StockIssuedDuringPeriodValueSaleOfSecurities
12186676 USD
CY2021Q2 izea Stock Issued During Period Value Employee Stock Purchase Plans And Stock Options Issued
StockIssuedDuringPeriodValueEmployeeStockPurchasePlansAndStockOptionsIssued
45942 USD
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
37544 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
333878 USD
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
206194 USD
CY2021Q2 izea Stock Issued During Period Value Shares Withheld To Cover Statutory Taxes
StockIssuedDuringPeriodValueSharesWithheldToCoverStatutoryTaxes
55386 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-111686 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
75273633 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
13718023 USD
izea Stock Issued During Period Value Sale Of Securities
StockIssuedDuringPeriodValueSaleOfSecurities
15361853 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2313 USD
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
62499 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
458032 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
248278 USD
us-gaap Net Income Loss
NetIncomeLoss
-7954603 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
20980331 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
31786360 USD
izea Stock Issued During Period Value Sale Of Securities
StockIssuedDuringPeriodValueSaleOfSecurities
46544688 USD
izea Stock Issued During Period Value Employee Stock Purchase Plans And Stock Options Issued
StockIssuedDuringPeriodValueEmployeeStockPurchasePlansAndStockOptionsIssued
48086 USD
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
72240 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1080835 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
404180 USD
izea Stock Issued During Period Value Shares Withheld To Cover Statutory Taxes
StockIssuedDuringPeriodValueSharesWithheldToCoverStatutoryTaxes
396962 USD
us-gaap Net Income Loss
NetIncomeLoss
-2104124 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
75273633 USD
us-gaap Net Income Loss
NetIncomeLoss
-2104124 USD
us-gaap Net Income Loss
NetIncomeLoss
-7954603 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1927220 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Depreciation
Depreciation
65687 USD
us-gaap Depreciation
Depreciation
70207 USD
izea Amortizationofsoftwaredevelopmentcostsandotherintangibleassets
Amortizationofsoftwaredevelopmentcostsandotherintangibleassets
663766 USD
izea Amortizationofsoftwaredevelopmentcostsandotherintangibleassets
Amortizationofsoftwaredevelopmentcostsandotherintangibleassets
808169 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
4300000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
7790 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
23706 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
107315 USD
us-gaap Share Based Compensation
ShareBasedCompensation
404180 USD
us-gaap Share Based Compensation
ShareBasedCompensation
248278 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
72240 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
62499 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
925744 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2436269 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
795576 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
53972 USD
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
0 USD
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
111421 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-255419 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1229576 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
193795 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-101561 USD
izea Changeincontractwithcustomerliability
Changeincontractwithcustomerliability
1474501 USD
izea Changeincontractwithcustomerliability
Changeincontractwithcustomerliability
-625502 USD
izea Change In Lease Liability
ChangeInLeaseLiability
0 USD
izea Change In Lease Liability
ChangeInLeaseLiability
24024 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3141704 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1820738 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
29689 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3287 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
8924 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
27487 USD
izea Payments To Proceeds From Developed Software
PaymentsToProceedsFromDevelopedSoftware
0 USD
izea Payments To Proceeds From Developed Software
PaymentsToProceedsFromDevelopedSoftware
97129 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20765 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-72929 USD
izea Proceeds From The Sale Of Securities Financing Activities
ProceedsFromTheSaleOfSecuritiesFinancingActivities
46544688 USD
izea Proceeds From The Sale Of Securities Financing Activities
ProceedsFromTheSaleOfSecuritiesFinancingActivities
15361853 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1080835 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74989876 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20820273 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
458032 USD
izea Proceeds From Employee Stock Purchase Plan And Stock Options Exercised
ProceedsFromEmployeeStockPurchasePlanAndStockOptionsExercised
48086 USD
izea Proceeds From Employee Stock Purchase Plan And Stock Options Exercised
ProceedsFromEmployeeStockPurchasePlanAndStockOptionsExercised
2313 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
396962 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
0 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1934587 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
7857 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
11410 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
45107120 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16829311 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
41944651 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14935644 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33045225 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5884629 USD
us-gaap Interest Paid Net
InterestPaidNet
5610 USD
us-gaap Interest Paid Net
InterestPaidNet
36594 USD
izea Equipmentacquiredwithfinancingarrangement
Equipmentacquiredwithfinancingarrangement
0 USD
izea Equipmentacquiredwithfinancingarrangement
Equipmentacquiredwithfinancingarrangement
43003 USD
izea Fairvalueofcommonstockissuedforfutureservices
Fairvalueofcommonstockissuedforfutureservices
147329 USD
izea Fairvalueofcommonstockissuedforfutureservices
Fairvalueofcommonstockissuedforfutureservices
125000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which COVID-19 impacts the Company’s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of COVID-19, the extent to which it impacts worldwide macroeconomic conditions, the speed of the anticipated recovery, access to capital markets, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of June 30, 2021 and through the date of the filing of this Quarterly Report on Form 10-Q. The accounting matters assessed included, but were not limited to estimates related to revenue, the accounting for potential liabilities and accrued expenses, the assumptions utilized in valuing stock-based compensation issued for services, the realization of deferred tax assets, and assessments of impairment related to long-lived assets, intangible assets, and goodwill. The Company’s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in additional material impacts to the Company’s consolidated financial statements in future reporting periods.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the Company’s efforts, the ultimate impact of COVID-19 depends on factors beyond the Company’s knowledge or control, including the duration and severity of the outbreak, as well as third-party actions taken to contain its spread and mitigate its public health effects. As a result, the Company is unable to estimate the full extent to which COVID-19 will impact its financial results or liquidity. In consideration of the effect of COVID-19 on the assumptions and estimates used in the preparation of the financial statements, the Company identified the goodwill impairment disclosed in Note 3 as a material adverse effect on its results of operations and financial position in the first quarter of fiscal 2020 that was caused by COVID-19’s effect on economic conditions and its business operations.</span></div>
CY2021Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2021Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
74700000 USD
CY2020Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
31400000 USD
CY2021Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
6114296 USD
CY2021Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
18653 USD
CY2020Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
5148213 USD
CY2020Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
58992 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
155000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
155000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentrations of credit risk with respect to accounts receivable have been typically limited because a large number of geographically diverse customers make up the Company’s customer base, thus spreading the trade credit risk. However, with the Company’s addition of SaaS customers, it has increased credit exposure on certain customers who carry significant credit balances related to their marketplace spend. The Company controls credit risk through credit approvals, credit limits, and monitoring procedures. The Company performs credit evaluations of its customers, but generally does not require collateral to support accounts receivable. The Company had two customers that accounted for 31% of total accounts receivable as of June 30, 2021 and no customer that accounted for an aggregate of more than 10% of total accounts receivable as of December 31, 2020. The Company had three customers that accounted for 36% of its revenue during the three months ended June 30, 2021 and one customer that accounted for 10% of its revenue during the three months ended June 30, 2020. The Company had one customer that accounted for 11% of its revenue during the six months ended June 30, 2021 and no customer that accounted for more than 10% of its revenue during the six months ended June 30, 2020.
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 USD
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 USD
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 operating_units
izea Amortizationperiodofsoftwaredevelopmentcosts
Amortizationperiodofsoftwaredevelopmentcosts
P5Y
izea Leaseterm
Leaseterm
P12M
izea Leaseterm
Leaseterm
P12M
izea Invoicepaymentterms
Invoicepaymentterms
P30D
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1927220 USD
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
809330 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
802910 USD
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
615544 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
571992 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
193786 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
230918 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6211469 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6139247 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6211469 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5705913 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6211469 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6211469 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6139247 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5705913 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
72222 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
505556 USD
us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P1M
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
72222 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
72222 USD
CY2019Q4 us-gaap Goodwill
Goodwill
8316722 USD
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4300000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
4016722 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021Q2 us-gaap Goodwill
Goodwill
4016722 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
4300000 USD
CY2021Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
3036810 USD
CY2020Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
3036810 USD
CY2021Q2 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1794558 USD
CY2020Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1564126 USD
CY2021Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1242252 USD
CY2020Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1472684 USD
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
0 USD
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
97129 USD
CY2021Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
3036810 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
2757 USD
CY2021Q2 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
1743404 USD
CY2020Q4 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
1504113 USD
CY2021Q2 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
127463 USD
CY2020Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
286455 USD
CY2021Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
31312 USD
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
30487 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
195295 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
103918 USD
CY2021Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
2097474 USD
CY2020Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1924973 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1927220 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
21796 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
33388 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
10420 USD
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
65604 USD
CY2021Q2 izea Number Of Operating Lease Liabilities
NumberOfOperatingLeaseLiabilities
1 lease
CY2020Q2 izea Number Of Operating Lease Liabilities
NumberOfOperatingLeaseLiabilities
1 lease
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
izea Proceeds From The Sale Of Securities Financing Activities
ProceedsFromTheSaleOfSecuritiesFinancingActivities
46544688 USD
CY2020Q1 izea Numberofindependentdirectors
Numberofindependentdirectors
5 directors
izea Number Of Non Executive Employees Eligible For Performance Bonuses
NumberOfNonExecutiveEmployeesEligibleForPerformanceBonuses
18 employee
izea Percentageofindividualownershipofcommonstock
Percentageofindividualownershipofcommonstock
0.10
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
42864 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
406405 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1618451 USD
CY2021Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
55991 USD
CY2020Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
52702 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
108398 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
111753 USD
izea Proceeds Received From Sale Of Employee Stock Purchase Plan
ProceedsReceivedFromSaleOfEmployeeStockPurchasePlan
5222 USD
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
3376 shares
izea Proceeds Received From Sale Of Employee Stock Purchase Plan
ProceedsReceivedFromSaleOfEmployeeStockPurchasePlan
1944 USD
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
9665 shares
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-111686 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-1791142 USD
us-gaap Net Income Loss
NetIncomeLoss
-2104124 USD
us-gaap Net Income Loss
NetIncomeLoss
-7954603 USD
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
61386913 shares
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36108073 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
58874526 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35394639 shares
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
0
CY2020Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.05
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.04
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.22
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2290374 shares
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2910885 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2356391 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2740994 shares
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6538739 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3135039 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11914371 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7898707 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6538739 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3135039 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11914371 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7898707 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6132949 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5207205 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8654765 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7180264 USD
izea Contract Length For Sales Commissions Payment
ContractLengthForSalesCommissionsPayment
1

Files In Submission

Name View Source Status
0001495231-21-000130-index-headers.html Edgar Link pending
0001495231-21-000130-index.html Edgar Link pending
0001495231-21-000130.txt Edgar Link pending
0001495231-21-000130-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
izea-20210630.htm Edgar Link pending
izea-20210630.xsd Edgar Link pending
izea-20210630_cal.xml Edgar Link unprocessable
izea-20210630_def.xml Edgar Link unprocessable
izea-20210630_htm.xml Edgar Link completed
izea-20210630_lab.xml Edgar Link unprocessable
izea-20210630_pre.xml Edgar Link unprocessable
izea210630ex311.htm Edgar Link pending
izea210630ex312.htm Edgar Link pending
izea210630ex321.htm Edgar Link pending
izea210630ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending